ADMA Biologics, Inc.

NasdaqGM:ADMA 주식 보고서

시가총액: US$2.5b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

ADMA Biologics 관리

관리 기준 확인 2/4

ADMA Biologics' CEO는 Adam Grossman, Jan2007 에 임명되었습니다 의 임기는 17.42 년입니다. 총 연간 보상은 $ 6.04M, 12.4% 로 구성됩니다. 12.4% 급여 및 87.6% 보너스(회사 주식 및 옵션 포함). 는 $ 26.04M 가치에 해당하는 회사 주식의 1.06% 직접 소유합니다. 26.04M. 경영진과 이사회의 평균 재임 기간은 각각 1.7 년과 11.9 년입니다.

주요 정보

Adam Grossman

최고 경영자

US$6.0m

총 보상

CEO 급여 비율12.4%
CEO 임기17.4yrs
CEO 소유권1.1%
경영진 평균 재임 기간1.7yrs
이사회 평균 재임 기간11.9yrs

최근 관리 업데이트

Recent updates

Is ADMA Biologics, Inc. (NASDAQ:ADMA) Trading At A 43% Discount?

May 30
Is ADMA Biologics, Inc. (NASDAQ:ADMA) Trading At A 43% Discount?

ADMA Biologics, Inc. Just Beat EPS By 45%: Here's What Analysts Think Will Happen Next

May 13
ADMA Biologics, Inc. Just Beat EPS By 45%: Here's What Analysts Think Will Happen Next

Giving ADMA Biologics A Well-Deserved 'Booyah'

May 12

ADMA Biologics, Inc.'s (NASDAQ:ADMA) Prospects Need A Boost To Lift Shares

May 08
ADMA Biologics, Inc.'s (NASDAQ:ADMA) Prospects Need A Boost To Lift Shares

Is ADMA Biologics (NASDAQ:ADMA) A Risky Investment?

Apr 04
Is ADMA Biologics (NASDAQ:ADMA) A Risky Investment?

Rising Margins And Product Promise Drive ADMA Biologics Forward (Rating Upgrade)

Apr 03

ADMA Biologics: On A Roll Entering 2024

Jan 19

Is There An Opportunity With ADMA Biologics, Inc.'s (NASDAQ:ADMA) 50% Undervaluation?

Jan 09
Is There An Opportunity With ADMA Biologics, Inc.'s (NASDAQ:ADMA) 50% Undervaluation?

ADMA Biologics, Inc. (NASDAQ:ADMA) Surges 30% Yet Its Low P/S Is No Reason For Excitement

Jan 09
ADMA Biologics, Inc. (NASDAQ:ADMA) Surges 30% Yet Its Low P/S Is No Reason For Excitement

We Think ADMA Biologics (NASDAQ:ADMA) Has A Fair Chunk Of Debt

Oct 25
We Think ADMA Biologics (NASDAQ:ADMA) Has A Fair Chunk Of Debt

We Think ADMA Biologics (NASDAQ:ADMA) Has A Fair Chunk Of Debt

Jun 10
We Think ADMA Biologics (NASDAQ:ADMA) Has A Fair Chunk Of Debt

The Market Doesn't Like What It Sees From ADMA Biologics, Inc.'s (NASDAQ:ADMA) Revenues Yet

May 12
The Market Doesn't Like What It Sees From ADMA Biologics, Inc.'s (NASDAQ:ADMA) Revenues Yet

ADMA Biologics: Strong Growth Is Clearing The Path To Profitability

Aug 21

ADMA Biologics GAAP EPS of -$0.07, revenue of $33.9M

Aug 10

ADMA Biologics (NASDAQ:ADMA) Is Carrying A Fair Bit Of Debt

Jun 01
ADMA Biologics (NASDAQ:ADMA) Is Carrying A Fair Bit Of Debt

ADMA Biologics: A Path To Profits Looks Clear

May 12

ADMA: Pertinent Updates

Apr 18

ADMA Biologics' 2021 Numbers Showed Continued Strong Execution

Mar 29

ADMA Biologics: 2021 Was Tough

Jan 18

ADMA Biologics (NASDAQ:ADMA) Is Carrying A Fair Bit Of Debt

Dec 02
ADMA Biologics (NASDAQ:ADMA) Is Carrying A Fair Bit Of Debt

ADMA Biologics: Turning A Corner

Nov 20

ADMA: Insiders Showing Their Cards

Nov 02

ADMA Biologics: Recent Significant Developments And Their Implications For The Stock

Aug 22

ADMA Biologics: Feeling Bullish After Encouraging Q2 Earnings Report

Aug 14

CEO 보상 분석

Adam Grossman 의 보수는 ADMA Biologics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-US$4m

Dec 31 2023US$6mUS$750k

-US$28m

Sep 30 2023n/an/a

-US$23m

Jun 30 2023n/an/a

-US$40m

Mar 31 2023n/an/a

-US$48m

Dec 31 2022US$3mUS$637k

-US$66m

Sep 30 2022n/an/a

-US$70m

Jun 30 2022n/an/a

-US$73m

Mar 31 2022n/an/a

-US$78m

Dec 31 2021US$4mUS$618k

-US$72m

Sep 30 2021n/an/a

-US$74m

Jun 30 2021n/an/a

-US$74m

Mar 31 2021n/an/a

-US$75m

Dec 31 2020US$2mUS$600k

-US$76m

Sep 30 2020n/an/a

-US$67m

Jun 30 2020n/an/a

-US$61m

Mar 31 2020n/an/a

-US$54m

Dec 31 2019US$2mUS$536k

-US$48m

Sep 30 2019n/an/a

-US$56m

Jun 30 2019n/an/a

-US$59m

Mar 31 2019n/an/a

-US$61m

Dec 31 2018US$2mUS$536k

-US$66m

Sep 30 2018n/an/a

-US$61m

Jun 30 2018n/an/a

-US$61m

Mar 31 2018n/an/a

-US$55m

Dec 31 2017US$3mUS$494k

-US$44m

보상 대 시장: Adam 의 총 보상 ($USD 6.04M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 6.80M ).

보상과 수익: 회사가 수익성이 없는 동안 Adam 의 보상이 증가했습니다.

CEO

Adam Grossman (47 yo)

17.4yrs

테뉴어

US$6,039,649

보상

Mr. Adam S. Grossman serves as Director at BioFlorida Inc since August 2021. He is the Co-Founder of ADMA Biologics, Inc. and has been its Chief Executive Officer and President since October 2011 and 2007...

리더십 팀

이름위치테뉴어보상소유권
Adam Grossman
Co-Founder17.4yrsUS$6.04m1.06%
$ 26.3m
Jerrold Grossman
Co-Founder & Vice Chairman of the Board17.4yrsUS$284.72k0.21%
$ 5.3m
Kaitlin Kestenberg
COO & Senior VP of Complianceless than a year데이터 없음0.048%
$ 1.2m
Drew Pantello
Vice President of Marketing & Corporate Developmentno data데이터 없음데이터 없음
Cindy Petersen
Executive Director of Human Resources2.4yrs데이터 없음데이터 없음
Skyler Bloom
Senior Director of Business Development & Corporate Strategyno data데이터 없음데이터 없음
Brad Tade
Vice President of Financial Operationsless than a year데이터 없음데이터 없음

1.7yrs

평균 재임 기간

47yo

평균 연령

경험이 풍부한 관리: ADMA 의 관리팀은 경험 (평균 재직 기간 1.7 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름위치테뉴어보상소유권
Adam Grossman
Co-Founder17.4yrsUS$6.04m1.06%
$ 26.3m
Jerrold Grossman
Co-Founder & Vice Chairman of the Board17.4yrsUS$284.72k0.21%
$ 5.3m
Bryant Fong
Independent Director12.1yrsUS$280.72k0.026%
$ 641.5k
Steven Elms
Independent Chairman17.4yrsUS$290.22k0.023%
$ 561.3k
Young Kwon
Independent Director2.7yrsUS$272.34k0.12%
$ 3.0m
Michael Green
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Lawrence Guiheen
Independent Director11.9yrsUS$275.09k0.056%
$ 1.4m
Roy Chemaly
Member of Scientific Advisory Board10yrs데이터 없음데이터 없음
Jordan Orange
Member of Scientific Advisory Board10yrs데이터 없음데이터 없음
Alison Finger
Independent Directorless than a yearUS$231.12k데이터 없음
Jean-Laurent Casanova
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Ann Falsey
Member of Scientific Advisory Boardno data데이터 없음데이터 없음

11.9yrs

평균 재임 기간

59yo

평균 연령

경험이 풍부한 이사회: ADMA 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 11.9 년).